KD

Kantibhai Dhanjibhai Patel

Active Director Director DIN 07255725
DIN 07255725 First appointment Aug 2015 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Kantibhai Dhanjibhai Patel

Data last updated:

Kantibhai Dhanjibhai Patel is a Director at Celiom Health Care Private Limited (since 2015). The company operates in Pharma.

DIN 07255725
Primary Designation Director
Industry Pharma
First Appointment 03 Aug 2015
Oldest Company Age 16 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Celiom Health Care Private Limited U24230GJ2010PTC062463
Director03 Aug 20152010Active

Board colleagues of Kantibhai Dhanjibhai Patel

NameDINCompanyDesignation
Niteshkumar Naginbhai Patel06769302Celiom Health Care Private LimitedDirector

Directorship timeline

Open interactive timeline →
Celiom Health Care Private Limited
Premium access

Shareholding and investment profile for Kantibhai Dhanjibhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kantibhai Dhanjibhai Patel

Kantibhai Dhanjibhai Patel currently holds 1 directorship: Celiom Health Care Private Limited (Director, since 03 Aug 2015).

Kantibhai Dhanjibhai Patel was first appointed on 03 Aug 2015 as Director at Celiom Health Care Private Limited.

The current boards of Kantibhai Dhanjibhai Patel's companies include Niteshkumar Naginbhai Patel (Celiom Health Care Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available